News
Sun Pharmaceutical Industries consolidated net profit rises 26.24% in the March 2026 quarter
22-May-2026 | 17:31
Sales rise 13.61% to Rs 14559.75 crore
Net profit of Sun Pharmaceutical Industries rose 26.24% to Rs 2714.03 crore in the quarter ended March 2026 as against Rs 2149.88 crore during the previous quarter ended March 2025. Sales rose 13.61% to Rs 14559.75 crore in the quarter ended March 2026 as against Rs 12815.58 crore during the previous quarter ended March 2025.
For the full year,net profit rose 5.04% to Rs 11479.42 crore in the year ended March 2026 as against Rs 10929.04 crore during the previous year ended March 2025. Sales rose 11.87% to Rs 58220.11 crore in the year ended March 2026 as against Rs 52041.25 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 14559.75 | 12815.58 | 14 | 58220.11 | 52041.25 | 12 |
| OPM % | 27.16 | 29.00 | - | 30.46 | 29.35 | - |
| PBDT | 4326.81 | 4279.82 | 1 | 19364.21 | 17005.37 | 14 |
| PBT | 3551.34 | 3616.03 | -2 | 16426.36 | 14429.98 | 14 |
| NP | 2714.03 | 2149.88 | 26 | 11479.42 | 10929.04 | 5 |
Powered by Capital Market - Live News
